Depot perphenazine decanoate and enanthate for schizophrenia-Reference-Cited by-同舟云学术

Depot perphenazine decanoate and enanthate for schizophrenia

Published:2005-07-20 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

David Anthony¹,Quraishi Seema N¹,Rathbone John²

Affiliation:

1. Institute of Psychiatry; De Crespigny Park BOX PO68 London UK SE5 8AF

2. Institute of Mental Health; Cochrane Schizophrenia Group; Gateway Building, University of Nottingham Innovation Park, Triumph Road Nottingham UK NG7 2TU

Publisher

Wiley

Subject

Pharmacology (medical)

Reference43 articles.

1. Clopenthixol decanoate and perphenazine enanthate in schizophrenic patients;Ahlfors;Acta Psychiatrica Scandinavica,1980

2. Double blind compartive trial with 2 depot neuroleptics (perphenazine enanthate and fluphenthixol decanoate with chronic schizophrenia;Eufe;Nervenarzt,1979

3. Perphenazine decanoate vs perphenazine enanthate efficacy and side effects in a 6 week double-blind, comparative study of 50 drug monitored psychotic patients;Knudsen;Acta Psychiatrica Scandinavica,1985

4. A comparative study of the longacting neuroleptics perphenazin enanthate and fluspirilene;Tegeler;Pharmakopsychiatrie Neuropsychopharmakologie,1979

5. Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazine decanoate, fluspirilene, penfluridol, perphenazine enanthate and pipothiazine palmitate;Angst;Arzneimittel Forschung,1975

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perphenazine for schizophrenia;Cochrane Database of Systematic Reviews;2015-03-06

2. Long-Term Pharmacological Management of Schizophrenia;Schizophrenia;2014

3. Pharmacological and Psychosocial Management of Mental, Neurological and Substance Use Disorders in Low- and Middle-Income Countries: Issues and Current Strategies;Drugs;2013-09

4. Bromperidol decanoate (depot) for schizophrenia;Cochrane Database of Systematic Reviews;2011-09-07

5. Les antipsychotiques injectables à action prolongée: Avis d'experts de l'Association des médecins psychiatres du Québec;The Canadian Journal of Psychiatry;2011-06